ha 1004 has been researched along with Innate Inflammatory Response in 2 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drouin, SM | 1 |
| Kiley, SC | 1 |
| Carlino, JA | 1 |
| Barnum, SR | 1 |
| Turunen, JP | 1 |
| Mattila, P | 1 |
| Renkonen, R | 1 |
2 other studies available for ha 1004 and Innate Inflammatory Response
| Article | Year |
|---|---|
Transforming growth factor-beta2 regulates C3 secretion in monocytes through a protein kinase C-dependent pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Complement C3; Drug Interactions; Humans; Inflammatio | 1998 |
cAMP mediates IL-1-induced lymphocyte penetration through endothelial monolayers.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium; Cell Movement; Cells, Cultured; Col | 1990 |